Stereoselective determination of cisapride, a prokinetic agent, in human plasma by chiral high-performance liquid chromatography with ultraviolet detection: Application to pharmacokinetic study

Zeruesenay Desta, Nadia V. Soukhova, Alan Morocho, Jae Park, Subena K. Mahal, David A. Flockhart

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We have developed a simple, sensitive, specific and reproducible stereoselective high-performance liquid chromatography technique for analytical separation of cisapride enantiomers and measurement of cisapride enantiomers in human plasma. A chiral analytical column (ChiralCel OJ) was used with a mobile phase consisting of ethanol-hexane-diethylamine (35:64.5:0.5, v/v/v). This assay method was linear over a range of concentrations (5-125 ng/ml) of each enantiomer. The limit of quantification was 5 ng/ml in human plasma for both cisapride enantiomers, while the limit of detection was 1 ng/ml. Intra- and inter-day C.V.s did not exceed 15% for all concentrations except at 12.5 ng/ml for EII (+)-cisapride, which was ~20 and 19%, respectively. The clinical utility of the method was demonstrated in a pharmacokinetic study of normal volunteers who received a 20 mg single oral dose of racemic cisapride. The preliminary pharmacokinetic data obtained using the method we describe here provide evidence for the first time that cisapride exhibits stereoselective disposition. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)263-272
Number of pages10
JournalJournal of Chromatography B: Biomedical Sciences and Applications
Volume744
Issue number2
DOIs
StatePublished - Jul 21 2000
Externally publishedYes

Fingerprint

Cisapride
Plasma (human)
Pharmacokinetics
High performance liquid chromatography
Enantiomers
Hexanes
Assays
Ethanol

Keywords

  • Cisapride

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Stereoselective determination of cisapride, a prokinetic agent, in human plasma by chiral high-performance liquid chromatography with ultraviolet detection : Application to pharmacokinetic study. / Desta, Zeruesenay; Soukhova, Nadia V.; Morocho, Alan; Park, Jae; Mahal, Subena K.; Flockhart, David A.

In: Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 744, No. 2, 21.07.2000, p. 263-272.

Research output: Contribution to journalArticle

@article{4f6ac04fc75049d8a7ad445a69cd4e03,
title = "Stereoselective determination of cisapride, a prokinetic agent, in human plasma by chiral high-performance liquid chromatography with ultraviolet detection: Application to pharmacokinetic study",
abstract = "We have developed a simple, sensitive, specific and reproducible stereoselective high-performance liquid chromatography technique for analytical separation of cisapride enantiomers and measurement of cisapride enantiomers in human plasma. A chiral analytical column (ChiralCel OJ) was used with a mobile phase consisting of ethanol-hexane-diethylamine (35:64.5:0.5, v/v/v). This assay method was linear over a range of concentrations (5-125 ng/ml) of each enantiomer. The limit of quantification was 5 ng/ml in human plasma for both cisapride enantiomers, while the limit of detection was 1 ng/ml. Intra- and inter-day C.V.s did not exceed 15{\%} for all concentrations except at 12.5 ng/ml for EII (+)-cisapride, which was ~20 and 19{\%}, respectively. The clinical utility of the method was demonstrated in a pharmacokinetic study of normal volunteers who received a 20 mg single oral dose of racemic cisapride. The preliminary pharmacokinetic data obtained using the method we describe here provide evidence for the first time that cisapride exhibits stereoselective disposition. Copyright (C) 2000 Elsevier Science B.V.",
keywords = "Cisapride",
author = "Zeruesenay Desta and Soukhova, {Nadia V.} and Alan Morocho and Jae Park and Mahal, {Subena K.} and Flockhart, {David A.}",
year = "2000",
month = "7",
day = "21",
doi = "10.1016/S0378-4347(00)00247-4",
language = "English (US)",
volume = "744",
pages = "263--272",
journal = "Journal of Chromatography B: Biomedical Sciences and Applications",
issn = "0378-4347",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Stereoselective determination of cisapride, a prokinetic agent, in human plasma by chiral high-performance liquid chromatography with ultraviolet detection

T2 - Application to pharmacokinetic study

AU - Desta, Zeruesenay

AU - Soukhova, Nadia V.

AU - Morocho, Alan

AU - Park, Jae

AU - Mahal, Subena K.

AU - Flockhart, David A.

PY - 2000/7/21

Y1 - 2000/7/21

N2 - We have developed a simple, sensitive, specific and reproducible stereoselective high-performance liquid chromatography technique for analytical separation of cisapride enantiomers and measurement of cisapride enantiomers in human plasma. A chiral analytical column (ChiralCel OJ) was used with a mobile phase consisting of ethanol-hexane-diethylamine (35:64.5:0.5, v/v/v). This assay method was linear over a range of concentrations (5-125 ng/ml) of each enantiomer. The limit of quantification was 5 ng/ml in human plasma for both cisapride enantiomers, while the limit of detection was 1 ng/ml. Intra- and inter-day C.V.s did not exceed 15% for all concentrations except at 12.5 ng/ml for EII (+)-cisapride, which was ~20 and 19%, respectively. The clinical utility of the method was demonstrated in a pharmacokinetic study of normal volunteers who received a 20 mg single oral dose of racemic cisapride. The preliminary pharmacokinetic data obtained using the method we describe here provide evidence for the first time that cisapride exhibits stereoselective disposition. Copyright (C) 2000 Elsevier Science B.V.

AB - We have developed a simple, sensitive, specific and reproducible stereoselective high-performance liquid chromatography technique for analytical separation of cisapride enantiomers and measurement of cisapride enantiomers in human plasma. A chiral analytical column (ChiralCel OJ) was used with a mobile phase consisting of ethanol-hexane-diethylamine (35:64.5:0.5, v/v/v). This assay method was linear over a range of concentrations (5-125 ng/ml) of each enantiomer. The limit of quantification was 5 ng/ml in human plasma for both cisapride enantiomers, while the limit of detection was 1 ng/ml. Intra- and inter-day C.V.s did not exceed 15% for all concentrations except at 12.5 ng/ml for EII (+)-cisapride, which was ~20 and 19%, respectively. The clinical utility of the method was demonstrated in a pharmacokinetic study of normal volunteers who received a 20 mg single oral dose of racemic cisapride. The preliminary pharmacokinetic data obtained using the method we describe here provide evidence for the first time that cisapride exhibits stereoselective disposition. Copyright (C) 2000 Elsevier Science B.V.

KW - Cisapride

UR - http://www.scopus.com/inward/record.url?scp=0034698245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034698245&partnerID=8YFLogxK

U2 - 10.1016/S0378-4347(00)00247-4

DO - 10.1016/S0378-4347(00)00247-4

M3 - Article

C2 - 10993514

AN - SCOPUS:0034698245

VL - 744

SP - 263

EP - 272

JO - Journal of Chromatography B: Biomedical Sciences and Applications

JF - Journal of Chromatography B: Biomedical Sciences and Applications

SN - 0378-4347

IS - 2

ER -